BOUDREAUX GAIL

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
BOUDREAUX GAIL's trades of Elevance Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
296.59
Quantity 85,340 +41.5%
Value US$4,680,046
Transaction date
Purchase
Price
101.90
Quantity 19,772 -3.8%
Value US$379,023
Transaction date
Purchase
Price
388.19
Quantity 89,866 -11.8%
Value US$4,506,355
Transaction date
Purchase
Price
287.12
Quantity 5,116 +3.5%
Value US$1,468,906
Transaction date
Purchase
Price
286.07
Quantity 2,334 +1.6%
Value US$667,687
Transaction date
Planned sale
Price
504.27
Quantity 2,250 -1.7%
Value US$1,134,608
Transaction date
Planned sale
Price
503.67
Quantity 1,000 -0.8%
Value US$503,670
Transaction date
Planned sale
Price
502.23
Quantity 2,250 -1.7%
Value US$1,130,018
Transaction date
Planned sale
Price
501.40
Quantity 6,621 -4.8%
Value US$3,319,769
Transaction date
Planned sale
Price
500.36
Quantity 20,779 -13.0%
Value US$10,396,980
Transaction date
Planned sale
Price
498.50
Quantity 1,100 -0.7%
Value US$548,350
Transaction date
Proposed sale
Price
500.98
Quantity 34,000
Value US$17,033,398
Transaction date
Purchase
Price
264.22
Quantity 2,000 +8.1%
Value US$528,440
Transaction date
Purchase
Price
263.52
Quantity 5,600 +29.5%
Value US$1,475,712
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-17
B Purchase
85,340 +41.5%
296.59
US$4,680,046 		85,340 +41.5% 296.59 US$4,680,046
2026-07-17 2026-07-17
B Purchase
19,772 -3.8%
101.90
US$379,023 		19,772 -3.8% 101.90 US$379,023
2025-07-18 2025-07-18
B Purchase
89,866 -11.8%
388.19
US$4,506,355 		89,866 -11.8% 388.19 US$4,506,355
2025-07-18 2025-07-18
B Purchase
5,116 +3.5%
287.12
US$1,468,906 		5,116 +3.5% 287.12 US$1,468,906
2025-07-18 2025-07-18
B Purchase
2,334 +1.6%
286.07
US$667,687 		2,334 +1.6% 286.07 US$667,687
2024-07-23 2024-07-22
PlS Planned sale
2,250 -1.7%
504.27
US$1,134,608 		2,250 -1.7% 504.27 US$1,134,608
2024-07-23 2024-07-22
PlS Planned sale
1,000 -0.8%
503.67
US$503,670 		1,000 -0.8% 503.67 US$503,670
2024-07-23 2024-07-22
PlS Planned sale
2,250 -1.7%
502.23
US$1,130,018 		2,250 -1.7% 502.23 US$1,130,018
2024-07-23 2024-07-22
PlS Planned sale
6,621 -4.8%
501.40
US$3,319,769 		6,621 -4.8% 501.40 US$3,319,769
2024-07-23 2024-07-22
PlS Planned sale
20,779 -13.0%
500.36
US$10,396,980 		20,779 -13.0% 500.36 US$10,396,980
2024-07-23 2024-07-22
PlS Planned sale
1,100 -0.7%
498.50
US$548,350 		1,100 -0.7% 498.50 US$548,350
2024-07-22 2024-07-22
PrS Proposed sale
34,000
500.98
US$17,033,398 		34,000 500.98 US$17,033,398
2020-01-31 2020-01-30
B Purchase
2,000 +8.1%
264.22
US$528,440 		2,000 +8.1% 264.22 US$528,440
2020-01-31 2020-01-30
B Purchase
5,600 +29.5%
263.52
US$1,475,712 		5,600 +29.5% 263.52 US$1,475,712
2019-02-06 2019-02-05
B Purchase
2,095 +inf%
119.33
US$249,988 		2,095 +inf% 119.33 US$249,988